MENU
COR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

COR stock forecast, quote, news & analysis

Cencora is one of three leading domestic pharmaceutical wholesalers... Show more

A.I.Advisor
published price charts
COR
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for COR with price predictions
Oct 12, 2026

COR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for COR turned positive on October 06, 2026. Looking at past instances where COR's MACD turned positive, the stock continued to rise in 34 of 54 cases over the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on COR as a result. In 51 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

COR moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where COR advanced for three days, in 240 of 390 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

COR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for COR crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.

The Aroon Indicator for COR entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 26 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. COR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.011) is normal, around the industry mean (2.488). P/E Ratio (22.555) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (0.636) is also within normal values, averaging (2.016). Dividend Yield (0.008) settles around the average of (0.004) among similar stocks. P/S Ratio (0.187) is also within normal values, averaging (4.260).

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I.Advisor
published Dividends

COR paid dividends on August 31, 2026

Cencora COR Stock Dividends
А dividend of $0.60 per share was paid with a record date of August 31, 2026, and an ex-dividend date of August 14, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 21.94B. The market cap for tickers in the group ranges from 44.8K to 99.84B. MCK holds the highest valuation in this group at 99.84B. The lowest valued company is COCM at 44.8K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -22%. AHG experienced the highest price growth at 17%, while ACH experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 59
Price Growth Rating: 54
SMR Rating: 87
Profit Risk Rating: 72
Seasonality Score: 22 (-100 ... +100)
COR's MACD Histogram crosses above signal line